Literature DB >> 8377033

Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.

R B Devereux1, M J Roman.   

Abstract

Increased left ventricular mass predicts myocardial infarction: Recent studies have demonstrated that increased left ventricular mass is a more potent predictor than is elevated blood pressure of myocardial infarction or death due to coronary heart disease in hypertensive patients. Other research has shown that hypertensive patients commonly have episodes of asymptomatic ischemic ST-segment depression. Several different factors appear to account for this close relationship between myocardial muscle mass and the occurrence of ischemia and vascular morbid events. These include an increased resting demand for coronary blood flow (to supply the greater amount of myocardium), atherosclerotic obstruction of large coronary arteries and reduced vasodilatory capacity of the coronary microcirculation due to arteriolar hypertrophy and dysregulation, each of which reduces the capacity of the coronary circulation to increase its blood flow during stress (coronary reserve). Increased risk in population with more severe hypertension: Increased ventricular mass and coronary arteriolar abnormalities appear especially important as mechanisms of myocardial ischemia in populations with more severe hypertension, whereas conventional coronary disease predominates in patients with mild hypertension and multiple standard risk factors. Need for further research to optimize therapy: To develop optimal therapeutic approaches, further research is needed to clarify the basis of the inter-relationships between left ventricular hypertrophy and arterial abnormalities, to determine whether cardiac microvascular abnormalities parallel systemic hemodynamic patterns in hypertension and to ascertain the relative importance of reversing or preventing cardiovascular hypertrophy and myocardial ischemia for improving the prognosis of hypertensive patients.

Entities:  

Mesh:

Year:  1993        PMID: 8377033

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  5 in total

1.  When should essential hypertension in childhood be treated and how?

Authors:  C Loirat
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 2.  Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease.

Authors:  T Störk; M Möckel; O Danne; H Völler; H Eichstädt; U Frei
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

3.  The impact of hypertension on patients with acute coronary syndromes.

Authors:  Claudio Picariello; Chiara Lazzeri; Paola Attanà; Marco Chiostri; Gian Franco Gensini; Serafina Valente
Journal:  Int J Hypertens       Date:  2011-06-22       Impact factor: 2.420

4.  Clinical effects of hypertension on the mortality of patients with acute myocardial infarction.

Authors:  Dong Goo Kang; Myung Ho Jeong; Yongkeun Ahn; Shung Chull Chae; Seung Ho Hur; Taek Jong Hong; Young Jo Kim; In Whan Seong; Jei Keon Chae; Jay Young Rhew; In Ho Chae; Myeong Chan Cho; Jang Ho Bae; Seung Woon Rha; Chong Jin Kim; Yang Soo Jang; Junghan Yoon; Ki Bae Seung; Seung Jung Park
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

Review 5.  Moexipril and left ventricular hypertrophy.

Authors:  George S Chrysant; P K Nguyen
Journal:  Vasc Health Risk Manag       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.